<!DOCTYPE html>
<!-- Generated by Aspose.Words for Java 21.2.0 --><html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>fedlex-data-admin-ch-eli-cc-2021-380-20210804-en-docx-1</title>
</head>
<body><div id="lawcontent">
<div id="preface">
<!--818.101.27--><p class="srnummer">818.101.27</p>
<?del-struct abstand4pt><?del-struct abstand4pt><?del-struct abstand4pt><p>English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.</p>
<?del-struct abstand18pt><h1 class="erlasstitel">Ordinance <br>on Measures to Combat <br>the Coronavirus (COVID-19) in <br>International Passenger Transport</h1>
<h2 class="erlasskurztitel">(COVID-19 Ordinance on International Passenger Transport Measures)</h2>
<?del-struct abstand18pt><p>of 23 June 2021 (Status as of 4 August 2021)</p>
</div>
<div id="preamble">
<p>The Swiss Federal Council,</p>
<p>on the basis of Article 41 paragraphs 1 and 3 of the Epidemics Act of <br>28 September 2012<sup><a href="#fn-d3709e36">1</a></sup> (EpidA),</p>
<p>ordains:</p>
<div class="footnotes"><p id="fn-d3709e36"><sup>1</sup> <i>AS <b>2021</b> 380</i> <a href="https://fedlex.data.admin.ch/eli/cc/2015/297/20200625">SR <b>818.101</b></a></p></div>
</div>
<main id="maintext"><section id="sec_1"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_1">Section 1 Purpose and Subject Matter </a>
</h1>
<div class="collapseable"> <article id="art_1"><a name="a1"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_1"><b>Art. 1</b> </a>
</h6>
<div class="collapseable">
<p><sup>1</sup> This Ordinance aims to prevent the cross-border spread of the Sars-Cov-2 coronavirus, and in particular variants of the virus of concern that are not yet prevalent in Switzerland.</p>
<p><sup>2</sup> It regulates specific health related measures on entering Switzerland for the following persons:</p>
<dl>
<dt>persons who enter Switzerland from a country or region with a variant of the virus of concern;</dt>
<dd></dd>
<dt>b. </dt>
<dd>persons who enter Switzerland by air.</dd>
</dl>
<p><sup>3</sup> It regulates the following measures for the persons specified in paragraph 2:</p>
<dl>
<dt>a. </dt>
<dd>recording contact data;</dd>
<dt>b. </dt>
<dd>the requirement to be tested before entering Switzerland and before departure when travelling to Switzerland by air;</dd>
<dt>c. </dt>
<dd>the requirement to quarantine and its enforcement.</dd>
</dl>
</div></article>
</div></section><section id="sec_2"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_2">Section 2 Countries and Regions with a Variant of the Virus of Concern </a>
</h1>
<div class="collapseable">
<br><article id="art_2"><a name="a2"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_2"><b>Art. 2</b> </a>
</h6>
<div class="collapseable">
<p><sup>1</sup> Categorisation as a country or region with a variant of the virus of concern requires proof or the presumption that in this country or region a variant of the virus is widespread:</p>
<dl>
<dt>a. </dt>
<dd>that carries a higher risk of infection or causes a more severe form of the disease than the variant of the virus that is prevalent in Switzerland; or</dd>
<dt>b. </dt>
<dd>that escapes detection and for which there is no defence through pre-existing immunity to the variant of the virus prevalent in Switzerland (immune evasive).</dd>
</dl>
<p><sup>2</sup> The list of countries and regions with a variant of the virus of concern that is immune evasive or the immune evasive status of which is unclear is provided in Annex 1 number 1.</p>
<p><sup>3</sup> The list of countries and regions with a variant of the virus of concern that is not immune evasive is provided in Annex 1 number 2.</p>
<p><sup>4</sup> Regions on the border with Switzerland which have close economic, social and cultural ties with Switzerland may be exempted from inclusion in the lists mentioned in paragraphs 2 and 3 even if they meet the requirements set out in paragraph 1.</p>
</div></article>
</div></section><section id="sec_3"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_3">Section 3 Recording Contact Data </a>
</h1>
<div class="collapseable"> <article id="art_3"><a name="a3"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_3"><b>Art. 3</b> <b></b>Persons subject to the requirement </a>
</h6>
<div class="collapseable"> <p><sup>1</sup> The requirement to record contact data pursuant to Article 49 of the Epidemics Ordinance of 29 April 2015<sup><a href="#fn-d3709e159">2</a></sup> applies to persons who: </p>
<dl>
<dt>a. </dt>
<dd>enter Switzerland from a country or region specified in Annex 1 number 1; or</dd>
<dt>b. </dt>
<dd>enter Switzerland by air. </dd>
</dl>
<p><sup>2</sup> An exemption to the requirement under paragraph 1 applies to persons who:</p>
<dl>
<dt>a. </dt>
<dd>carry goods or passengers across the border in terms of their professional activities; or</dd>
<dt>b. </dt>
<dd>travel through Switzerland without a stopover.</dd>
</dl>
<div class="footnotes"><p id="fn-d3709e159"><sup>2</sup>  <a href="https://fedlex.data.admin.ch/eli/cc/2015/298/20190301">SR <b>818.101.1</b></a></p></div>
</div></article><article id="art_4"><a name="a4"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_4"><b>Art. 4</b> <b></b>Obligations of persons subject to the requirement </a>
</h6>
<div class="collapseable"> <p><sup>1</sup> The persons specified in Article 3 must record their contact data before entry as follows:</p>
<dl>
<dt>a. </dt>
<dd>online by means of the platform for recording contact data for travellers<sup><a href="#fn-d3709e214">3</a></sup> provided by the Federal Office of Public Health (FOPH); or </dd>
<dt>b. </dt>
<dd>on the paper contact forms provided by the FOPH.</dd>
</dl>
<p><sup>2</sup> Persons who enter Switzerland from a country or region specified in Annex 1 number 1 but not as a passenger with a passenger transport operator pursuant to Article 5 and who record their contact details on a contact form must retain the form for 14 days.</p>
<div class="footnotes"><p id="fn-d3709e214"><sup>3</sup>  The platform for recording contact data for travellers can be accessed at https://swissplf.admin.ch</p></div>
</div></article><article id="art_5"><a name="a5"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_5"><b>Art. 5</b> <b></b>Obligations for passenger transport operators<b> </b> </a>
</h6>
<div class="collapseable"> <p><sup>1</sup> Rail, bus, ship or airline operators carrying passengers specified in Article 3 internationally shall ensure that passengers provide their contact data in accordance with Article 4 paragraph 1. </p>
<p><sup>2</sup> They shall send the contact data under Article 4 paragraph 1 letter b to the FOPH on request within 24 hours. </p>
<p><sup>3</sup> They shall retain the contact data for 14 days and thereafter destroy the data.</p>
<p><sup>4</sup> They shall send the FOPH on request within 48 hours lists of all cross-border train, bus or ship journeys or flights that they have scheduled for the following month. </p>
<p><sup>5</sup> They shall send the contact data under Article 4 paragraph 1 letter b and the lists under paragraph 4 via the platform for passenger transport operators<sup><a href="#fn-d3709e261">4</a></sup> provided by the FOPH.</p>
<div class="footnotes"><p id="fn-d3709e261"><sup>4</sup>  The platform for passenger transport operators can be accessed at https://swissplf.admin.ch</p></div>
</div></article><article id="art_6"><a name="a6"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_6"><b>Art. 6</b> <b></b>Duties of the FOPH and the cantons </a>
</h6>
<div class="collapseable"> <p><sup>1</sup> The FOPH shall ensure that the contact data is available in order to enforce the quarantine requirement under Article 9 and that the data is forwarded immediately to the cantons responsible for the persons entering Switzerland. </p>
<p><sup>2</sup> As soon as it is notified that a person infected with Sars-CoV-2 has entered Switzerland, the FOPH shall take the following measures:</p>
<dl>
<dt>a. </dt>
<dd>It shall request the passenger transport operator to provide the contact data recorded on paper relating to the persons who entered Switzerland at the same time as the person infected with Sars-CoV-2.</dd>
<dt>b. </dt>
<dd>It shall establish the identity of the persons who were in close contact with the person infected with Sars-CoV-2 on the basis of contact data recorded online and the contact data in accordance with letter a.</dd>
<dt>c. </dt>
<dd>It shall forward the processed contact data immediately to the cantons responsible for the persons entering Switzerland.</dd>
</dl>
<p><sup>3</sup> The FOPH may delegate its duties under paragraphs 1 and 2 to third parties. In doing so, it shall ensure that data protection and data security are guaranteed.</p>
<p><sup>4</sup> The FOPH or the third parties shall destroy the data one month after the entry of the persons concerned.</p>
<p><sup>5</sup> The cantons shall destroy the data one month after they have received the same from the FOPH or from third parties.</p>
</div></article>
</div></section><section id="sec_4"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_4">Section 4 Air Travel: Requirement to be tested before Departure </a>
</h1>
<div class="collapseable"> <article id="art_7"><a name="a7"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_7"><b>Art. 7</b> </a>
</h6>
<div class="collapseable">
<p><sup>1</sup> Airlines must inform their passengers that they must be tested for Sars-CoV-2 before departure and that they will only be permitted to board the aircraft if they can provide a negative test result. </p>
<p><sup>2</sup> Airlines must verify before departure whether a negative test result is available that is based on a procedure that corresponds to the current state of the art in science and technology. The test sample for:</p>
<dl>
<dt>a. </dt>
<dd>a molecular-biological analysis for Sars-CoV-2 must not have been taken more than 72 hours previously;</dd>
<dt>b. </dt>
<dd>an immunological Sars-CoV-2-rapid test must not have been taken more than 48 hours previously. </dd>
</dl>
<p><sup>3</sup> The document with the test result must contain the following information:</p>
<dl>
<dt>a. </dt>
<dd>the surname, first name and date of birth of the person tested;</dd>
<dt>b. </dt>
<dd>the date and time of taking the sample;</dd>
<dt>c. </dt>
<dd>the form of test pursuant to paragraph 2 letter a or b;</dd>
<dt>d. </dt>
<dd>the test result itself. </dd>
</dl>
<p><sup>4</sup> Airlines must not permit passengers who are unable to provide a negative test result under paragraph 2 to board the aircraft. </p>
<p><sup>5</sup> They may carry the following passengers without these passengers being required to produce a negative test result: </p>
<dl>
<dt>a. </dt>
<dd>children under 16 years of age; </dd>
<dt>b. </dt>
<dd>persons who can provide a medical certificate to prove that they must be transported to Switzerland as a matter of urgency on medical grounds;</dd>
<dt>c. </dt>
<dd>persons who have Swiss citizenship or hold a residence permit issued by Switzerland and who are unable to be tested for Sars-CoV-2 within a reasonable time or at reasonable expense; the persons concerned must sign a declaration confirming the lack of opportunity; </dd>
<dt>d. </dt>
<dd>persons who are using a Swiss airport while in transit without leaving that airport before continuing their journey;</dd>
<dt>e. </dt>
<dd>persons who provide proof that they have been vaccinated against Sars-CoV-2; the persons who are regarded as having been vaccinated, the duration for which the vaccination is regarded as effective and the accepted forms of proof regulated in Annex 2;</dd>
<dt>f. </dt>
<dd>persons who provide proof that they have been infected with Sars-CoV-2 and have recovered; the duration of the exemption from the requirement to be tested and the accepted forms of proof are regulated in Annex 2;</dd>
<dt>g. </dt>
<dd>persons who provide proof in the form of a medical certificate that they are unable on medical grounds to take a Sars-CoV-2 test.</dd>
</dl>
<p><sup>6</sup> Persons entering Switzerland from the countries or regions specified in Annex 1 number 1 are not eligible for the exemptions from the requirement to be tested before departure under paragraph 5 letters e and f. </p>
</div></article>
</div></section><section id="sec_5"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_5">Section 5  Requirement for Persons entering Switzerland to be tested, to quarantine and to report  </a>
</h1>
<div class="collapseable">
<br><article id="art_8"><a name="a8"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_8"><b>Art. 8</b> Persons required to be tested and to quarantine </a>
</h6>
<div class="collapseable"> <p><sup>1</sup> Persons entering Switzerland who have at any time within the 10 days before entry stayed in a country or region specified in Annex 1 must be tested and must comply with the rules on quarantine under Article 9.</p>
<p><sup>2</sup> The following persons are exempted from the requirement to be tested and to quarantine under Article 7:</p>
<dl>
<dt>a. </dt>
<dd>persons whose work in Switzerland is essential to maintain:<dl>
<dt>1. </dt>
<dd>the efficiency of the health service,</dd>
<dt>2. </dt>
<dd>public security and order,</dd>
<dt>3. </dt>
<dd>the efficiency of institutional beneficiaries as defined in Article 2 paragraph 1 of the Host State Act of 22 June 2007<sup><a href="#fn-d3709e457">5</a></sup>,</dd>
<dt>4. </dt>
<dd>Switzerland’s diplomatic and consular relations;</dd>
</dl>
</dd>
<dt>b. </dt>
<dd>persons who in the course of their professional activities transport passengers or goods across borders;</dd>
<dt>c. </dt>
<dd>persons who as transit passengers have stayed less than 24 hours in a country or region specified in Annex 1;</dd>
<dt>d. </dt>
<dd>persons who enter Switzerland solely for the purpose of transiting the country and who intend and are able to travel on directly to another country;</dd>
<dt>e.  </dt>
<dd>persons who enter Switzerland from the countries or regions specified in Annex 1 number 2 and who can prove that they have been vaccinated against Sars-CoV-2; the persons who are regarded as having been vaccinated, the duration for which the vaccination is regarded as effective and the accepted forms of proof regulated in Annex 2;</dd>
<dt>f.  </dt>
<dd>persons who enter Switzerland from the countries or regions specified in Annex 1 number 2 and who can prove that they have been infected with Sars-CoV-2 and that they have recovered; the duration of the exemption and the accepted forms of proof are regulated in Annex 2.</dd>
</dl>
<p><sup>3</sup> The following persons are also exempted from the requirement to be tested in paragraph 1:</p>
<dl>
<dt>a. </dt>
<dd>children under the age of 16;</dd>
<dt>b. </dt>
<dd>persons who can prove that they are unable on medical grounds to take a Sars-CoV-2 test.</dd>
</dl>
<p><sup>4</sup> Paragraph 2 does not apply to persons displaying symptoms of COVID-19, unless the person concerned can provide certified medical evidence that the symptoms have a different cause.</p>
<p><sup>5</sup> The competent cantonal authority may in justified cases permit further exemptions from the requirement to be tested and to quarantine or may relax certain conditions.</p>
<div class="footnotes"><p id="fn-d3709e457"><sup>5</sup> <a href="https://fedlex.data.admin.ch/eli/cc/2007/860/20080101">SR <b>192.12</b></a></p></div>
</div></article><article id="art_9"><a name="a9"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_9"><b>Art. 9</b> Requirement to be tested and to quarantine </a>
</h6>
<div class="collapseable"> <p><sup>1</sup> Persons subject to the requirement to be tested and to quarantine under Article 8 must prove that they have undergone a molecular-biological analysis for Sars-CoV-2 within the past 72 hours or have taken a immunological Sars-CoV-2 rapid test within the past 48 hours and that the result of the test is negative.</p>
<p><sup>2</sup> They are required on entry to travel immediately and directly to their home or to other suitable accommodation. They must remain there without leaving at any time for 10 days following their entry (quarantine on entry).</p>
<p><sup>3</sup> Where a person has entered Switzerland from a country or region that does not have a variant of the virus of concern, the responsible cantonal authority may take account of the duration of the person’s stay in that country or region when calculating the time to be spent in quarantine under paragraph 2.</p>
<p><sup>4</sup> Persons under paragraph 1 and under Article 7 paragraph 5 letter c who are unable to provide proof of a negative test on entering Switzerland must immediately undergo one of the following tests on entry:</p>
<dl>
<dt>a. </dt>
<dd>a molecular-biological analysis for Sars-CoV-2; or</dd>
<dt>b. </dt>
<dd>a Sars-CoV-2 rapid test according to the diagnostic standard.</dd>
</dl>
<p><sup>5</sup> Persons required to quarantine on entry may leave quarantine within 10 days provided they undergo either a molecular-biological analysis for Sars-CoV-2 or a Sars-CoV-2-rapid test that meets the diagnostic standard and the result is negative. The test may be carried out at the earliest on the seventh day of quarantine. The competent cantonal authority may, in justified cases, suspend the early termination of quarantine.</p>
<p><sup>6</sup> Persons who leave quarantine early pursuant to paragraph 5 must wear a face mask and maintain a distance of at least 1.5 metres from other persons when outside their home or accommodation until the point in time at which quarantine under paragraph 2 would have ended.</p>
</div></article><article id="art_10"><a name="a10"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_10"><b>Art. 10</b> <b></b>Requirement to report </a>
</h6>
<div class="collapseable"> <p>Persons subject to the requirement to be tested and to quarantine on entry under this Ordinance must report to the responsible cantonal authority within two days of their arrival in Switzerland and must follow the instructions given by the authority.</p>
</div></article>
</div></section><section id="sec_6"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_6">Section 6 Checks and Reports by Border Control Authorities </a>
</h1>
<div class="collapseable"> <article id="art_11"><a name="a11"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_11"><b>Art. 11</b> </a>
</h6>
<div class="collapseable">
<p><sup>1</sup> The border control authorities may conduct risk-based checks on persons entering Switzerland from countries or regions with a variant of the virus of concern. In doing so, they shall verify:</p>
<dl>
<dt>a. </dt>
<dd>that the person checked has tested negative in accordance with Article 9 paragraph 1; </dd>
<dt>b. </dt>
<dd>that the contact data of the person checked has been recorded in accordance with Article 4 paragraph 1.</dd>
</dl>
<p><sup>2</sup> If the person checked is unable to produce a negative test result or show that their contact data has been recorded, the border control authority shall report the matter to the responsible cantonal authority. The report shall include the details of the person checked, the time and place of the check, the address the person has specified in Switzerland, and the outcome of the check.</p>
<p><sup>3</sup> The border control authorities may impose fixed penalty fines.</p>
</div></article>
</div></section><section id="sec_7"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_7">Section 7 Updating the Annexes </a>
</h1>
<div class="collapseable"> <article id="art_12"><a name="a12"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_12"><b>Art. 12</b> </a>
</h6>
<div class="collapseable">
<p><sup>1</sup> The Federal Department of Home Affairs shall update Annex 1 continuously in consultation with the Federal Department of Justice and Police, the Federal Department of Finance and the Federal Department of Foreign Affairs.</p>
<p><sup>2</sup> It shall update Annex 2 in accordance with the latest scientific knowledge and in consultation with the Federal Commission for Vaccination.</p>
</div></article>
</div></section><section id="sec_8"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#sec_8">Section 8 Final Provisions </a>
</h1>
<div class="collapseable"> <article id="art_13"><a name="a13"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_13"><b>Art. 13</b> Repeal and amendment of other legislation </a>
</h6>
<div class="collapseable"> <p><sup>1</sup> The COVID-19-Ordinance on International Passenger Transport Measures of 27 January 2021<sup><a href="#fn-d3709e643">6</a></sup> is repealed.</p>
<p><sup>2</sup> The amendment of other legislation is regulated in Annex 3.</p>
<div class="footnotes"><p id="fn-d3709e643"><sup>6</sup>  [<i>AS <b>2021</b> 61</i>, <i>94</i>, <i>276</i>, <i>298</i>, <i>352</i>]</p></div>
</div></article><article id="art_14"><a name="a14"></a><h6 class="heading" role="heading">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#art_14"><b>Art. 14</b> Commencement </a>
</h6>
<div class="collapseable"> <p>This Ordinance comes into force on 26 June 2021 at 00.00.</p>
</div></article>
</div></section></main><div id="annex">
<section id="annex_1"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1">Annex 1</a><i><sup><a href="#fn-d3709e685">7</a></sup></i><a href="#annex_1"> </a>
</h1>
<div class="footnotes"><p id="fn-d3709e685"><sup>7</sup> Amended by No I of the FDHA O of 3 Aug. 2021, in force since 4 Aug. 2021  (<i>AS <b>2021</b> 465</i>).</p></div>
<div class="collapseable">
<p>(Art. 2 paras. 2 and 3, 3 para. 1 let. a, 4 para. 2, 7 para. 6, 8 paras. 1 and 2 let. e and f and 12 para. 1)</p>
<section id="annex_1/lvl_d1199e28"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_d1199e28">List of countries and regions with a variant of the virus of concern</a><b><sup><sup><a href="#fn-d3709e703">8</a></sup></sup></b><a href="#annex_1/lvl_d1199e28"> </a>
</h2>
<div class="footnotes"><p id="fn-d3709e703"><sup>8</sup> If a state is on the list, this includes all its areas, islands and overseas territories, even if these are not separately listed.</p></div>
<div class="collapseable">
<section id="annex_1/lvl_d1199e28/lvl_1"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_d1199e28/lvl_1">1. Countries and regions with a variant of the virus of concern that is immune evasive is or the immune evasive status of which is unclear (Art. 2 paras. 1 and 2) </a>
</h3>
<div class="collapseable"><p>There are no entries currently on this list</p></div></section><section id="annex_1/lvl_d1199e28/lvl_2"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_1/lvl_d1199e28/lvl_2">2. Countries and regions with a variant of the virus of concern that is not immune evasive (Art. 2 paras. 1 and 3) </a>
</h3>
<div class="collapseable"><p>There are no entries currently on this list</p></div></section>
</div></section>
</div></section><section id="annex_2"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_2">Annex 2 </a>
</h1>
<div class="collapseable">
<p>(Art. 7 para. 5 let. e and f, 8 para. 2 let. e and f and 12 para. 2)</p>
<section id="annex_2/lvl_d1199e32"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_2/lvl_d1199e32">Persons who have been vaccinated and who have recovered </a>
</h2>
<div class="collapseable">
<section id="annex_2/lvl_d1199e32/lvl_1"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_2/lvl_d1199e32/lvl_1">1 Persons who have been vaccinated </a>
</h3>
<div class="collapseable"> <p>1.1 Persons who have been vaccinated are persons who have received a vaccine that: </p>
<dl>
<dt>a. </dt>
<dd>is authorised in Switzerland and which has been administered in full in accordance with the FOPH recommendations; </dd>
<dt>b. </dt>
<dd>has been authorised by the European Medicines Agency for the European Union and has been administered in full in accordance with the requirements or recommendations of the country in which the vaccination was administered; or</dd>
<dt>c. </dt>
<dd>is authorised under the WHO Emergency Use Listing and has been administered in full in accordance with the requirements or recommendations of the country in which the vaccination was administered.</dd>
</dl>
<p>1.2 The vaccination is regarded as being effective for 12 months from the date on which it was administered in full; the Janssen vaccine is regarded as being effective for 12 months from the 22nd day after it was administered in full. </p>
<p>1.3 Proof of vaccination may be provided in the form of a COVID-19 certificate in accordance with Article 1 letter a number 1 of the COVID-19 Certificates Ordinance of 4 June 2021<sup><a href="#fn-d3709e752">9</a></sup> or a recognised foreign certificate in accordance with Section 7 of the COVID-19 Certificates Ordinance.</p>
<p>1.4 Proof may also be provided in a different form from that in number 1.3. It must be a form of proof that is customary at the time. In addition to the surname, forename and date of birth of the person concerned, it must include the following information:</p>
<dl>
<dt>a. </dt>
<dd>the date of vaccination;</dd>
<dt>b. </dt>
<dd>the vaccine used.</dd>
</dl>
<div class="footnotes"><p id="fn-d3709e752"><sup>9</sup>  <i>SR <b>818.102.2</b></i></p></div>
</div></section><section id="annex_2/lvl_d1199e32/lvl_2"><h3 class="heading" role="heading" aria-level="3">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_2/lvl_d1199e32/lvl_2">2 Persons who have recovered </a>
</h3>
<div class="collapseable"> <p>2.1 Proof of recovery remains valid for 6 months from the 11th day following confirmation of the infection.</p>
<p>2.2 Proof of recovery may be provided in the form of a COVID-19 certificate in accordance with Article 1 letter a number 2 of the COVID-19 Certificates Ordinance of 4 June 2021 or a recognised foreign certificate in accordance with Section 7 of the COVID-19 Certificates Ordinance.</p>
<p>2.3 Proof may also be provided in a different form from that in number 2.2. It must be a form of proof that is customary at the time. In addition to the surname, forename and date of birth of the person concerned, it must include the following information:</p>
<dl>
<dt>a. </dt>
<dd>confirmation of the infection including the name and address of the confirming body (test centre, doctor, pharmacy, hospital);</dd>
<dt>b. </dt>
<dd>confirmation that isolation has been terminated or confirmation from a doctor of recovery.</dd>
</dl>
</div></section>
</div></section>
</div></section><section id="annex_3"><h1 class="heading" role="heading" aria-level="1">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_3">Annex 3 </a>
</h1>
<div class="collapseable">
<p>(Art. 13 para. 2)</p>
<section id="annex_3/lvl_d1199e36"><h2 class="heading" role="heading" aria-level="2">
<span class="display-icon"></span><span class="external-link-icon"></span><a href="#annex_3/lvl_d1199e36">Amendment of another act </a>
</h2>
<div class="collapseable">
<p>...<sup><a href="#fn-d3709e805">10</a></sup></p>
<div class="footnotes"><p id="fn-d3709e805"><sup>10</sup> The amendments may be consulted under <i>AS <b>2021</b> 380</i>.</p></div>
</div></section>
</div></section>
</div>
</div></body>
</html>
